دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Waning of COVID-19 vaccine effectiveness: individual and public health risk
VanessaPiechottaaThomasHardera
Prophylaxis with anti-activated factor XII for hereditary angioedema
Lauré MFijenaMarcelLevia
Prioritise research on vaccines for pregnant and breastfeeding women
TerraMancaaFrançoiseBaylisbFlor MMunozcKarina ATopa
The bleak future of Afghan women's health under the Taliban
LambaSabooraLidaAhmadbAyeshaAhmadacd
The Lancet journals: our new ombudsperson
Editors of the Lancet journalsa
Offline: Ukraine and the lessons of Alexander Herzen
RichardHorton
International Women's Day: dismay at alcohol and arms ties
SophieCousins
Activists welcome Colombia's decriminalisation of abortion
AmyBooth
Sally Grantham-McGregor: pioneer in early childhood development
UdaniSamarasekera
Apartheid logic in global health
Mosoka PFallahabcEricReinhartdef
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
AnnikaFendleraScott T CShepherdaoLewisAuaoMaryWubRuthHarveycAndreas MSchmittoZaydTippuaoBenjaminShumaoSheimaFaragoAljosjaRogiersoEleanorCarlyleoKimEdmondsoLyraDel RosariooKarlaLingardoMaryMangwendeoLucyHoltoHamidAhmodoJustineKortewego…SamraTurajlicaoy
COVID-19 booster doses in pregnancy and global vaccine equity
ErkanKalafataLaura AMageebPetervon DadelszenbPaulHeathcAsmaKhalilde
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
ProfLorcan PMcGarveyMDaProfSurinder SBirringMDbProfAlyn HMoriceMDcProfPeter VDicpinigaitisMDdProfIan DPavordMDeJonathanSchelfhoutPhDfAllison MartinNguyenMSfQingLiPhDfAnjelaTzontchevaPhDfBeataIskoldPharmDfStuart AGreenMDfCarmen LaRosaMDfDavid RMuccinoMDfProfJaclyn ASmithPhDgCOUGH-1 and COUGH-2 Investigators*
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel RFeikinMDa†Melissa MHigdonMPHb†Laith JAbu-RaddadPhDdNickAndrewsPhDeRafaelAraosMDfgYairGoldbergPhDhMichelle JGroomePhDjkAmitHuppertPhDiKatherine LO'BrienMDaProfPeter GSmithDSclAnneliesWilder-SmithMDaProfScottZegerPhDcMariaDeloria KnollPhDb†Minal KPatelMDaâ€
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
ProfTimothyCraigDOaProfMarkusMagerlMDbProfDonald SLevyMDcAvnerReshefMDdProfWilliam RLumryMDeInmaculadaMartinez-SaguerMDfJoshua SJacobsMDgWilliam HYangMDhProfBruceRitchieMDiEmelAygören-PürsünMDjProfPaul KKeithMDkPaulaBusseMDlHenrikeFeuersengerPhDmDiptiPawaskarPhDnoIrisJacobsMDnIngoPragstPhDmMittie KDoyleMDnp
Calvarial hyperostosis in primary hyperparathyroidism and other settings of increased cAMP signalling
Elizabeth HThengBAaLee SWeinsteinMDbMichael TCollinsMDa
Time for united action on depression: a Lancet–World Psychiatric Association Commission
ProfHelenHerrmanMDab*ProfVikramPatelPhDcef*ChristianKielingMDgi*ProfMichaelBerkPhDj†ClaudiaBuchweitzMAh†ProfPimCuijpersPhDk†ProfToshiaki AFurukawaMDm†ProfRonald CKesslerPhDd†ProfBrandon AKohrtMDx†ProfMarioMajPhDn†ProfPatrickMcGorryMDab†ProfCharles FReynoldsIIIMDo†ProfMyrna MWeissmanPhDpqr†DixonChibandaPhDstProfChristopherDowrickMDuProfLouise MHowardPhDvProfChristina WHovenDrPHpqrProfMartinKnappPhDw…ProfMirandaWolpertPsychDad
